Jump to content
 







Main menu
    


Navigation  


●Main page
 ●Contents
 ●Current events
 ●Random article
 ●About Wikipedia
 ●Contact us
 ●Donate
  



Contribute  


●Help
 ●Learn to edit
 ●Community portal
 ●Recent changes
 ●Upload file
  







Search  

































●Create account

●Log in
 









●Create account
 ● Log in
  



Pages for logged out editors learn more  


●Contributions
 ●Talk
  


















Contents

   



(Top)
  


1 See also  




2 References  













Etaqualone






●日本語
 ●Српски / srpski
 ●Srpskohrvatski / српскохрватски
 ●Suomi
 ●Tiếng Việt
  
Edit links
  








●Article
 ●Talk
  
















●Read
 ●Edit
 ●View history
  







Tools
    


Actions  


●Read
 ●Edit
 ●View history
  



General  


●What links here
 ●Related changes
 ●Upload file
 ●Special pages
 ●Permanent link
 ●Page information
 ●Cite this page
 ●Get shortened URL
 ●Download QR code
 ●Wikidata item
  



Print/export  


●Download as PDF
 ●Printable version
  



In other projects  


●Wikimedia Commons
  















Appearance
    

 





From Wikipedia, the free encyclopedia
  

Etaqualone
Clinical data
Routes of
administration		Oral
ATC code
  • none
Legal status
Legal status
  • In general: unscheduled
Identifiers

  • 3-(2-ethylphenyl)-2-methyl-quinazolin-4-one

CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC17H16N2O
Molar mass264.328 g·mol−1
3D model (JSmol)

  • O=C1C2=CC=CC=C2N=C(C)N1C3=CC=CC=C3CC

  • InChI=1S/C17H16N2O/c1-3-13-8-4-7-11-16(13)19-12(2)18-15-10-6-5-9-14(15)17(19)20/h4-11H,3H2,1-2H3 checkY

  • Key:UVTJKLLUVOTSOB-UHFFFAOYSA-N checkY

 ☒NcheckY (what is this?)  (verify)

Etaqualone (Aolan, Athinazone, Ethinazone[1]) is a quinazolinone-class GABAergic and is an analogue of methaqualone that was developed in the 1960s[2][3] and marketed mainly in France and some other European countries. It has sedative, hypnotic, muscle relaxant and central nervous system depressant properties resulting from its agonist activity at the β-subtype of the GABAA receptor, and was used for the treatment of insomnia.

The dosage and effects are reported to be similar to those of methaqualone, but shorter acting and slightly weaker. Typical reports use between 50 and 500 mg of etaqualone, depending on desired effects. Old pharmaceutical formulations of Ethinazone were 350 mg tablets. Etaqualone is thought to act in a similar way to barbiturates and benzodiazepines by increasing the sensitivity of GABAA receptors [citation needed]. Recreational effects include euphoria, relaxation, increased sociability and sexuality, reduction of short-term memory, and loss of coordination. Combination with other depressants has a potentiating effect and can cause overdose. Tolerance to benzodiazepines or alcohol will also reduce effects.

Ethaqualone can be present as a free base, insoluble in water but soluble in alcohol and nonpolar solvents, or as a water-soluble hydrochloride salt which is about 85% as potent as the freebase by weight.

The most common route of administration of etaqualone is oral, but snorting the salt or smoking the free base have also been reported.

See also[edit]

References[edit]

  1. ^ Pflegel P, Wagner G (November 1967). "[On the polarography of 2-methyl-3-(2-methylphenyl)-3,4-dihydroquinazolinone-(4) methaqualone, Dormutil) and 2-methyl-3-(2-ethylphenyl-3,4-dihydroquinazolinone-(4) (ethinazone, Aolan). 5. Polarography of heterocyclic compounds]" [On the Polarography of 2-Methyl-3-(2-methylphenyl)-3,4-dihydroquinazolinone-(4) (methaqualone, Dormutil) and 2-methyl-3-(2-ethylphenyl-3,4-dihydroquinazolinone-(4) (ethinazone, Aolan). 5. Polarography of Heterocyclic Compounds]. Die Pharmazie (in German). 22 (11): 643–50. PMID 5619478.
  • ^ GB patent 936902, "Quinazolinone Derivatives", issued 1963-09-18, assigned to Beiersdorf 
  • ^ Parmar SS, Kishor K, Seth PK, Arora RC (January 1969). "Role of alkyl substitution in 2,3-disubstituted and 3-substituted 4-quinazolones on the inhibition of pyruvic acid oxidation". Journal of Medicinal Chemistry. 12 (1): 138–41. doi:10.1021/jm00301a035. PMID 4303122.
    • Stub icon

    This sedative-related article is a stub. You can help Wikipedia by expanding it.

  • t
  • e

    • Retrieved from "https://en.wikipedia.org/w/index.php?title=Etaqualone&oldid=1225579326"
    Categories: 
    ●Drugs not assigned an ATC code
     ●Sedatives
     ●Quinazolinones
     ●Designer drugs
     ●GABAA receptor positive allosteric modulators
     ●Sedative stubs
     Hidden categories: 
    ●CS1 German-language sources (de)
     ●Articles with short description
     ●Short description matches Wikidata
     ●Drugs with non-standard legal status
     ●Articles with changed EBI identifier
     ●Chemical pages without DrugBank identifier
     ●Articles without KEGG source
     ●Drugboxes which contain changes to verified fields
     ●Drugboxes which contain changes to watched fields
     ●All articles with unsourced statements
     ●Articles with unsourced statements from April 2019
     ●All stub articles
      


    ●This page was last edited on 25 May 2024, at 11:06 (UTC).
    ●Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.


    ●Privacy policy
    ●About Wikipedia
    ●Disclaimers
    ●Contact Wikipedia
    ●Code of Conduct
    ●Developers
    ●Statistics
    ●Cookie statement
    ●Mobile view


    Wikimedia Foundation
    Powered by MediaWiki